LTR Pharma’s innovative nasal spray for erectile dysfunction, SPONTAN is featured in a Stockhead article by Nadine McGrath titled “ASX stocks striving to inject youthfulness into an aging world population”
The article highlights the investment opportunities in ASX-listed companies that are addressing issues associated with longevity and the ageing population.
“LTP executive director Lee Rodne says SPONTAN is looking to bring back youthful spontaneity of sex, providing on-demand delivery and faster effect than the pills of old.
“We’re committed to bringing the world’s first fast-acting, on-demand nasal spray treatment for ED to men globally so they can live in the moment and be spontaneous,” he says.